IESE (España)
-
Supermarket Baqueira
Fernandes, NunoExercise FE-55-EFinanceThe supermarket chain Baqueira is considering investing in a new delivery service for online orders. The project will have a life span of five years.Starting at €8.20
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €5.74
-
Sony and the Activist Threat
Fernandes, NunoCase F-970-EFinanceThis case is about an activist shareholder attacking Sony. On May 14 2013, Third Point, the activist shareholder, delivered a letter to Kazuo Hirai, president and CEO of Sony Corporation (Sony). The letter revealed that Third Point had purchased a 6.9% stake in Sony and proposed that Sony spin off up to 20% of its Entertainment Division to reduce its debt and strengthen its ailing Electronics Division. Activist fund Third Point had a history of ...Starting at €8.20
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €8.20
-
The International Airline Group Rights Issue
Fernandes, NunoCase F-965-EFinanceThis case is about the IAG capital increase, in the aftermath of the COVID-19 crisis. COVID-19 had totally changed the airline sector, and worldwide all airlines were in despair. IAG was badly in need of additional capital. International Airlines Group (IAG), the owner of airlines such as Iberia and British Airways, had announced a capital increase, through a rights issue. According to the Board, the capital increase of almost ? 3 billion was de...Starting at €8.20
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €5.74
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €8.20
-
Supermercado Baqueira
Fernandes, NunoExercise FE-55FinanceLa cadena de supermercados Baqueira está estudiando la posibilidad de invertir en un nuevo servicio de entrega para los pedidos por internet. El proyecto tendrá una duración de cinco años.Starting at €8.20